| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Dimesna | NSC-716976; BNP-7787; LP-300 | Phase 2 Clinical | Bionumerik | Adenocarcinoma of Lung; Anemia; Breast Diseases; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug-Related Side Effects and Adverse Reactions; Lung Neoplasms; Neoplasm Metastasis; Neutropenia | Details |